Medtech Service Provider HuKui Bio raised US$5.5M for US market expansion
The medtech service provider Hukui Bio (互貴興業) announced that it has raised US$5.5 million in Series C funding, led by Yellowstone Holding AG from Switzerland, totalling US$11.8M funding to date.
HuKui Bio will collaborate with venture capital funds in the Bay area, in addition to the biomedical innovation clusters and accelerators in Europe and the US. The New Business Department and the US subsidiary in the Bay area were founded at the beginning of 2021, with the onboarding of Dr IC Jan (詹益鑑) as its Chief Strategy Officer.